RegMed Investors’ (RMi) pre-open: WTF

December 20, 2024

BUY, SELL or just HOLD – it’s worth a dice throw anticipating the coming read of the Fed’s inflation gauge and the latest iteration of budget turbulence

Pre-open Indications: 4 Positive and 4 Negative Suppositions

The personal consumption expenditures price index, the Fed’s preferred inflation gauge, showed an increase of just 0.1% from October.

• The measure indicated a 2.4% inflation rate on an annual basis, still ahead of the Fed’s 2% goal but lower than the 2.5% estimate
• Excluding food and energy, core PCE also increased 0.1% monthly and was 2.8% higher from a year ago, with both readings also being 0.1% point below the forecast. Fed officials generally consider the core reading to be a better gauge of long-run inflation trends as it excludes the volatile gas and groceries category.

Never leave an investor uninform

Read more »

RegMed Investors (RMi) Closing Bell: all cell and gene therapy sector stocks snap to attention

December 20, 2024

Braced by “uncle algo and his electronic trading dwarfs” famished for stock treats

The threat of a government shutdown continues after 2 failed attempts by House Republicans in recent days to avert a stoppage

I say today what others won't, so you can do what others can't by sticking to the FACTS!

Never leave an investor uninformed!  

The week in Review

Read more »